170 related articles for article (PubMed ID: 10964754)
21. Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells.
Coppo P; Dusanter-Fourt I; Millot G; Nogueira MM; Dugray A; Bonnet ML; Mitjavila-Garcia MT; Le Pesteur D; Guilhot F; Vainchenker W; Sainteny F; Turhan AG
Oncogene; 2003 Jun; 22(26):4102-10. PubMed ID: 12821944
[TBL] [Abstract][Full Text] [Related]
22. [Targeted blockage of STAT5 by a decoy oligodeoxynucleotide inhibits the growth and proliferation of K562 cells].
Wang XZ; Feng WL; Shi M; Zeng JM; Tu ZG; Huang ZG
Zhonghua Xue Ye Xue Za Zhi; 2004 Dec; 25(12):724-7. PubMed ID: 15730714
[TBL] [Abstract][Full Text] [Related]
23. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
Gross AW; Ren R
Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343
[TBL] [Abstract][Full Text] [Related]
24. Functional cooperation among Ras, STAT5, and phosphatidylinositol 3-kinase is required for full oncogenic activities of BCR/ABL in K562 cells.
Sonoyama J; Matsumura I; Ezoe S; Satoh Y; Zhang X; Kataoka Y; Takai E; Mizuki M; Machii T; Wakao H; Kanakura Y
J Biol Chem; 2002 Mar; 277(10):8076-82. PubMed ID: 11779872
[TBL] [Abstract][Full Text] [Related]
25. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
[TBL] [Abstract][Full Text] [Related]
26. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.
Iavnilovitch E; Groner B; Barash I
Mol Cancer Res; 2002 Nov; 1(1):32-47. PubMed ID: 12496367
[TBL] [Abstract][Full Text] [Related]
27. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells.
Matsumura I; Kitamura T; Wakao H; Tanaka H; Hashimoto K; Albanese C; Downward J; Pestell RG; Kanakura Y
EMBO J; 1999 Mar; 18(5):1367-77. PubMed ID: 10064602
[TBL] [Abstract][Full Text] [Related]
29. STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo.
Kijima T; Niwa H; Steinman RA; Drenning SD; Gooding WE; Wentzel AL; Xi S; Grandis JR
Cell Growth Differ; 2002 Aug; 13(8):355-62. PubMed ID: 12193474
[TBL] [Abstract][Full Text] [Related]
30. Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters.
Stephanou A; Brar BK; Knight RA; Latchman DS
Cell Death Differ; 2000 Mar; 7(3):329-30. PubMed ID: 10866494
[No Abstract] [Full Text] [Related]
31. FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism.
Fernández de Mattos S; Essafi A; Soeiro I; Pietersen AM; Birkenkamp KU; Edwards CS; Martino A; Nelson BH; Francis JM; Jones MC; Brosens JJ; Coffer PJ; Lam EW
Mol Cell Biol; 2004 Nov; 24(22):10058-71. PubMed ID: 15509806
[TBL] [Abstract][Full Text] [Related]
32. Depsipeptide enhances imatinib mesylate-induced apoptosis of Bcr-Abl-positive cells and ectopic expression of cyclin D1, c-Myc or active MEK abrogates this effect.
Kawano T; Horiguchi-Yamada J; Iwase S; Akiyama M; Furukawa Y; Kan Y; Yamada H
Anticancer Res; 2004; 24(5A):2705-12. PubMed ID: 15517875
[TBL] [Abstract][Full Text] [Related]
33. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
Bartusel T; Schubert S; Klempnauer KH
Gene; 2005 May; 351():171-80. PubMed ID: 15922873
[TBL] [Abstract][Full Text] [Related]
34. STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5.
Paukku K; Silvennoinen O
Cytokine Growth Factor Rev; 2004 Dec; 15(6):435-55. PubMed ID: 15561601
[TBL] [Abstract][Full Text] [Related]
35. SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice.
Golas JM; Arndt K; Etienne C; Lucas J; Nardin D; Gibbons J; Frost P; Ye F; Boschelli DH; Boschelli F
Cancer Res; 2003 Jan; 63(2):375-81. PubMed ID: 12543790
[TBL] [Abstract][Full Text] [Related]
36. Critical role of STAT5 activation in transformation mediated by ZNF198-FGFR1.
Heath C; Cross NC
J Biol Chem; 2004 Feb; 279(8):6666-73. PubMed ID: 14660670
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of antiapoptotic genes in human endometrial carcinoma: bcl-XL succeeds bcl-2 function in neoplastic cells.
Crescenzi E; Criniti V; Pianese M; Tecce MF; Palumbo G
Gynecol Oncol; 2000 Jun; 77(3):419-28. PubMed ID: 10831353
[TBL] [Abstract][Full Text] [Related]
38. BCR-ABL fails to inhibit apoptosis in U937 myelomonocytic cells expressing a carboxyl-terminal truncated STAT5.
Ahmed M; Dusanter-Fourt I; Dugray A; Dubrez L; Novault S; Bonnet ML; Gisselbrecht S; Varet B; Solary E; Vainchenker W; Turhan AG
Leuk Lymphoma; 2001 Jul; 42(3):445-55. PubMed ID: 11699409
[TBL] [Abstract][Full Text] [Related]
39. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.
Nieborowska-Skorska M; Wasik MA; Slupianek A; Salomoni P; Kitamura T; Calabretta B; Skorski T
J Exp Med; 1999 Apr; 189(8):1229-42. PubMed ID: 10209040
[TBL] [Abstract][Full Text] [Related]
40. Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events.
Quintanilla-Martinez L; Kremer M; Specht K; Calzada-Wack J; Nathrath M; Schaich R; Höfler H; Fend F
Am J Pathol; 2003 May; 162(5):1449-61. PubMed ID: 12707028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
